International Trade Bulletin - Volume 1, Issue 6
Client Alert | 2 min read | 05.30.06
Inside this issue:
- EUROPE IN THE SPOTLIGHT
- INTERNATIONAL LABOR & EMPLOYMENT LAW IN THE SPOTLIGHT
- U.S. Sex Harassment and Retaliation Law: Toyota has been hit with a lawsuit seeking $190 million in damages arising out of a claim of sex harassment filed against the company and its former top U.S. executive
- EU Employee's Rights: Companies Engaging in Mergers and Acquisitions in Europe Must Pay Close Attention to Employees' Rights
- ANTI-DUMPING: The Court of International Trade (CIT) confirms U.S. antidumping application of the revised reseller rule
- CHINA: Exporters Criticize Draft China Export Limits
- MARKET ACCESS: United States and Vietnam Reach Bilateral Agreement on WTO Accession Opening Up Vietnam 's Market to U.S. Goods and Services
- EXPORT CONTROLS: New computer control parameter
- EMBARGOS: Oil Concerns Prompt Effort To Relax Cuban Embargo
- PENALTIES: BIS and OFAC Penalties Increase
- EXPORT CONTROLS: Deemed Export Policy Review
- ONLINE ADVERTISING: Operating Through the Borderless Internet Still Requires Compliance with Domestic Laws: Online Advertising—Guidance on Disclosures
Contacts
Insights
Client Alert | 2 min read | 09.18.25
On September 9, 2025, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (HHS) issued a news release announcing an “aggressive[]” “crackdown” on direct-to-consumer pharmaceutical advertising. This release came on the heels of a Presidential Memorandum President Trump issued the same day directing HHS to “ensure transparency and accuracy in direct-to-consumer prescription drug advertisements,” and the FDA to “take action to enforce legal requirements that advertisements for prescription drugs be truthful and not misleading.”
Client Alert | 3 min read | 09.17.25
Client Alert | 4 min read | 09.17.25
Client Alert | 5 min read | 09.16.25
Bucking the Odds: Why Technology Companies Should Embrace Software Patents Today
